Article info
PDFPoster Presentation
Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
Citation
Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
Publication history
- First published November 7, 2013.
Online issue publication
March 11, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© The Author(s). 2013